Important notice regarding the forthcoming 42th JSHCT Annual meeting in Tokyo
February 25, 2020
We regret having to cancel the 42nd Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation scheduled on March 5-7, 2020. We are very sorry to inform you this decision at the last moment.
The decision was made based upon the recent endemic of novel coronavirus infection (COVID-19) that has not been under control yet and kept spreading out. We truly sorry for making this decision and deeply apologize for all the inconvenience that you may have. The decision was made in consideration of not only health issues of attendees, but also the public safety issues that the majority of attendees are heavily involved in the care of their immunocompromised patients.
Further information regarding issues caused by this meeting cancellation will be notified as it’s decided.
We appreciate your kind understanding and cooperation, and sincerely hope this global threat of infection will be over soon.
Shuichi Taniguchi, MD, PhD
President of the 42nd Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation
Shinichiro Okamoto, MD, PhD
Chairman of the Board, the Japan Society for Hematopoietic Cell Transplantation